3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obesity
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Malignant Primary Pelvic Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Heart Defects, Congenital
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8
1
Carcinoma, Merkel Cell
1
Anxiety Disorders
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Bevacizumab
52
Cetuximab
46
Fluorouracil
45
Oxaliplatin
39
Leucovorin
37
pembrolizumab
32
Specimen Handling
28
Irinotecan
25
Biopsy
17
Magnetic Resonance Spectroscopy
16
Nivolumab
15
HMPL-013
14
Folfox protocol
14
Capecitabine
14
trifluridine tipiracil drug combination
12
Panitumumab
12
Gemcitabine
12
Cisplatin
11
Carboplatin
10
balstilimab
9
IFL protocol
9
Trifluridine
8
Standard of Care
8
Pemetrexed
8
Early Intervention, Educational
8
130-nm albumin-bound paclitaxel
8
encorafenib
7
Radiotherapy
7
Paclitaxel
7
Educational Status
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Exercise Test
×
90 days
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts